DIALYSIS · CCN 312500

DaVita Belmar Dialysis

WALL, NJ 07719

DialysisProfitDaVita
$4.3M
TOTAL REVENUE
16.6%
OPERATING MARGIN
2 / 5
STAR RATING
12
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$4.3M
Total costs
$3.5M
Operating income (rev − costs)
$704K
Operating margin
16.6%
Total charges
$2.2M
Total treatments
8,423
Dialysis stations
19

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

12 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
1.2891—
Fistula Rate
DFC_FISTULA_RATE
56.270—
Five Star Rating
DFC_FIVE_STAR
2——
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
0——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
164.667—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.62——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
2170—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
17.6181—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
26.744—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
33.4100—
Standardized ED Visits Ratio
DFC_SEDR
1.2937—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
44.430—